youtube
UnitedHealth Group posted strong adjusted quarterly performance, raising its full-year outlook as robust Medicare momentum helped offset stubbornly high commercial cost trends.
Here is what you need to know about the healthcare leader’s latest earnings metrics:
• THE INTAKE: The corporation reported adjusted earnings per share of 6.38 dollars on a massive top-line revenue foundation of 112 billion dollars.
• ELEVATED OUTLOOK: Driven by reliable operations, management increased its full-year adjusted earnings guidance to an updated range of 19.50 to 20.00 dollars per share.
• THE COST PROBLEM: Commercial medical cost trends spiked modestly above 11 percent, an elevated rate that will likely extend UnitedHealth’s margin recovery timeline past 2027.
• SHAREHOLDER RETURN: To reward long-term investors, the company bumped its annualized dividend to 9.28 dollars while outlining a 5 billion dollar share repurchase initiative.
• THE QUANT RATING: Weighing excellent baseline care services against the persistent pressure of commercial medical expenses, the Seeking Alpha Quant system leaves the stock at a Hold.
|
